Alot of stocks in recent times have seen their stock decline immediately after approval. Usually it's due to what's known as bear raids, as exposed short sellers take down the price intentionally so they can cover. Most of these stocks recovered strongly afterwards. I haven't seen an FDA approved drug in a while that has near the potential of this one since the company can basically go in and take the majority of the market away from other, non-effective treatments. Folks will be surprised here in the next few days, as this name gets more and more traction along with more coverage. Incredible future here for sure and if the stock doesn't double in a year from now, I'd be really surprised.